Amount$8M
SeriesSeries B
AnnouncedNov 15, 2021
SectorLife Sciences, Cancer, Genomics, Genome Sequencing
Solid
A solid round with healthy fundamentals.
Round size vs peers
Smaller than the typical Series B round.
Heuristic read of round size vs peers, syndicate size, insider conviction, and investor track record. Not investment advice.
vs. Series B rounds (996)
Round size distribution8th pct
smaller Series B roundslarger
